dipyridamole has been researched along with Cicatrization in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Cicatrization: The formation of fibrous tissue in the place of normal tissue during the process of WOUND HEALING. It includes scar tissue formation occurring in healing internal organs as well as in the skin after surface injuries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Requena, L | 1 |
| Fariña, C | 1 |
| Barat, A | 1 |
| Beller, G | 1 |
1 review available for dipyridamole and Cicatrization
| Article | Year |
|---|---|
Nuclear cardiology: current indications and clinical usefulness.
Topics: Angina Pectoris; Angioplasty, Balloon; Cardiology; Cardiomyopathies; Cicatrix; Coronary Artery Bypas | 1985 |
1 other study available for dipyridamole and Cicatrization
| Article | Year |
|---|---|
Degos disease in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Atrophy; Cicatrix; Dipyridamole; Erythema; Homosexuality, Male; | 1998 |